Skip to main content
  • Subscribe to our new MS newsletter

    Subscribe to our new MS newsletter

    Subscribe to our free Multiple Sclerosis newsletter to learn more about MS treatments, research, clinical trials, our providers, and more.

    Subscribe here.


Multiple Sclerosis & Neuroimmunology

MS clinic

The Multiple Sclerosis Clinic at Duke provides excellent patient care as well as clinical and basic research concerning immune diseases of the central nervous system. All of our providers have been named MS Certified Specialists by the Consortium of MS Centers.

Our providers have experience with a variety of injectable, oral, and infusion treatments for MS. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.

Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.

Latest News

News  -  Multiple Sclerosis & Neuroimmunology

Staff Spotlight: Nora Bobonis, RN, BSN

Tuesday, January 2, 2018
As the resource nurse for Duke’s Multiple Sclerosis clinic, Nora Bobonis, BSN, RN, has her hands full, educating patients about their condition,...Read more
News  -  Neurocritical Care, General & Community Neurology, Memory Disorders, Multiple Sclerosis & Neuroimmunology, Parkinson's Disease And Movement Disorders, Stroke and Vascular Neurology, Simon Davis, PhD

2017 - A year in review (part 2 of 2)

Friday, December 29, 2017
For the Duke Department of Neurology, the second year of 2017 was as eventful at the first, starting with a bittersweet farewell for Mark Stacy, MD...Read more
S Gregory
News  -  Multiple Sclerosis & Neuroimmunology

MS division shines at NMSS Impact Series

Friday, December 15, 2017
Members of the Multiple Sclerosis and Neuroimmunology division played a leadership role at the recent National Multiple Sclerosis Society’s (NMSS)...Read more